An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

Scale AI said it’s cutting 14% of its staff weeks after Meta invested $14.3 billion in the startup and hired a number of top ...